Global Contraceptives Market: Snapshot
The global contraceptives market is gaining from the increasing number of awareness campaigns that propagate contraceptives to be the effective method to prevent unintended pregnancy. Celebrity endorsements of these campaigns is particularly favoring the use of contraceptives among young adults who have the mindset to imitate famous people.
In urban areas, modern education and career aspirations have been crucial factors for the increasing use of contraceptives. Increasing number of women in the workforce and practices of seeking expert help for delayed pregnancy are driving the adoption of contraceptives.
Proving to challenge the market’s growth are side effects associated with hormonal contraception which is slowing their adoption among wary consumers.
As per a report by Transparency Market Research, the global contraceptives market is likely to rise at a CAGR of 6.1% between 2017 and 2025, for the market to be evaluated at US$37,242.7 mn by the end of 2025 from its worth of US$22,050.0 mn in 2016.
Contraceptive Devices Preferred due to Attributes of Effective, Long Lasting Contraception
In this report, the global contraceptives market is studied on the basis of product type, distribution channel, and region. On the basis of product type, the segments into which this market is divided are contraceptive drugs and contraceptive devices. The segment of contraceptive drugs is further sub-segmented into oral contraceptive, contraceptive injectable, and topical contraceptive patch. Oral contraceptive is further segmented into combined contraceptives and mini pills.
Contraceptive devices is segmented into male contraceptives and female contraceptives. Female contraceptives is further sub-segmented into female condoms, contraceptive sponges, contraceptive diaphragms, contraceptive vaginal rings, sub-dermal contraceptive plants, intrauterine devices, and non-surgical permanent contraception devices. The segment of contraceptive devices dominate the overall market, with the segment holding the leading 53.2% market share in 2016. This is mainly because of rising demand for intrauterine devices due to their safe, effective, and long lasting contraceptive benefits.
The segment of oral contraceptives within contraceptive drugs is anticipated to register the leading growth over the forecast period. This is attributed to the ease of availability of oral contraception, increasing awareness of pills among women, and development of low cost generic drugs.
Based on distribution channel, the global contraceptives market is segmented into hospitals pharmacy, independent pharmacy, online platform, clinics, and others. Hospital pharmacy is further segmented into public and private. Among the key distribution channel segments, hospital pharmacy leads the overall contraceptives market. Hospital pharmacy held the leading 34.7% market share in 2016 backed by favorable public and private funding and reimbursement facility for contraception treatment and ease in access of over the counter and prescribed drug at hospital pharmacy.
Asia Pacific to Emerge as Significant Market in Future
The global contraceptives market has been segmented into North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa based on geography. North America leads among other key regional markets with the region holding a share of 35.0% in 2016. The factors contributing to the growth of North America contraceptives market include rising prevalence of unintended pregnancies, rising trend of delayed child bearing, and growing usage of contraceptives among teenagers.
Europe stood as the second-leading region for contraceptives in 2016. The growth of this market is mainly due to easy availability of modern contraceptives and reimbursement provision for long term reversible contraceptive treatment.
However, Asia Pacific is projected to display the leading growth rate over the forecast period. Government initiatives to raise awareness to prevent unintended pregnancies, extensive population base in China and India creating massive demand for contraceptives, and rapid economic development are factors that will contribute to the growth of Asia Pacific contraceptives market.
Leading players in the global contraceptives market include Cipla Inc., Bayer AG, Merck Co. Inc., Teva Pharmaceutical Industries Ltd., Allergan plc, Pfizer Inc., Reckitt Benckiser plc, Mankind Pharma, Janssen Pharmaceutical Company, HLL Lifecare Limited, and Mithra Pharmaceuticals among others.
Global Contraceptives Market: Overview
The report on the contraceptive market analyzes the current and future scenario of the global market. Increase in prevalence of unintended pregnancy, advent of new low cost generics drugs and devices of contraceptives by key players, and increase in adoption and awareness for contraceptives usage in developing countries are the major drivers of the global contraceptive market.
The contraceptive market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global contraceptive market with respect to the segments based on product type, distribution channel and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises porter’s five forces analysis and value chain analysis to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global contraceptive market.
Global Contraceptives Market: Market Segmentation
Based on product type, the contraceptive market is segmented as contraceptives drugs and contraceptive devices. The contraceptive drug is further segmented into oral contraceptive, contraceptive injectable, and topical contraceptive patch. Oral contraceptive is further segmented into combined contraceptives and mini-pills. Contraceptive devices is segmented into male contraceptives and female contraceptives. Female contraceptive is segmented into female condoms, contraceptive diaphragms, contraceptive sponges, contraceptive vaginal rings, intrauterine devices, sub-dermal contraceptive implants, and non-surgical permanent contraception devices. The product market segments have been analyzed based on available drugs and devices, product pipeline for new contraceptives products, cost-effectiveness, and preference for contraceptive product among population. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.
Based on distribution channel, contraceptives market is segmented into hospitals pharmacy, independent pharmacy, online platform, clinics and others. The market segments have been extensively analyzed based on availability of different contraceptive products, availability of these products at different distribution channels and geographical coverage. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.
Geographically, the global contraceptive market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, Russia, France, Spain, Italy, and Rest of Europe), Asia Pacific (Japan, India, China, Australia & New Zealand and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.
Global Contraceptives Market: Competitive Landscape
The report also profiles major players in the global contraceptive market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report includes Merck & Co., Inc., Cipla Inc., Allergan plc, Bayer AG, HLL Lifecare Limited, Mankind Pharma, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Mithra Pharmaceuticals, Janssen Pharmaceutical Company, Reckitt Benckiser Group plc., and others.
The Global Contraceptives Market is segmented as given below:
Global Contraceptives Market, by Product
- Contraceptive Drugs
- Oral Contraceptives
- Combined Contraceptives
- Contraceptive Injectable
- Topical Contraceptive Patch
- Oral Contraceptives
- Contraceptive Devices
- Male Contraceptive Devices
- Female Contraceptive Devices
- Female Condoms
- Contraceptive Diaphragms
- Contraceptive Sponges
- Contraceptive Vaginal Rings
- Intrauterine Devices
- Sub-dermal Contraceptives Implants
- Non-Surgical Permanent Contraception Devices
Global Contraceptives Market, by Distribution Channel
- Hospitals Pharmacy
- Independent Pharmacy
- Online Platform
Global Contraceptive Market, by Geography
- North America
- Rest of Europe
- Asia Pacific
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- GCC countries
- South Africa
- Rest of Middle East & Africa